Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:6508
TSE:6508Machinery

Meidensha (TSE:6508) Q3 EPS Surge To ¥167.77 Tests One Off Gain Concerns

Meidensha (TSE:6508) has reported Q3 2026 revenue of ¥72.7 billion and basic EPS of ¥167.77, with trailing twelve month basic EPS at ¥489.22. The company has seen revenue move from ¥70.98 billion in Q3 2025 to ¥72.7 billion in Q3 2026, while quarterly basic EPS shifted from ¥84.58 a year ago to ¥167.77 most recently. This sets up a results season in which investors are likely to pay close attention to how net income of ¥7,611 million translates into the quality and resilience of margins. See...
NYSE:V
NYSE:VDiversified Financial

Visa (V) Valuation Check After Strong Q1 Results And Stablecoin Expansion

Visa (V) just posted fiscal first quarter results that beat expectations, with net revenue up 15% and payments volume near US$4t, while also pointing to more moderate growth in the coming quarter. See our latest analysis for Visa. Despite the strong quarter and fresh buyback and dividend activity, Visa's recent share price performance has cooled, with a 30 day share price return of 8.23% and a year to date share price return of 7.11%. At the same time, the 1 year total shareholder return of...
TSE:2127
TSE:2127Capital Markets

Nihon M&A Center Holdings (TSE:2127) Net Margin Surge Tests Profit Sustainability Narratives

Nihon M&A Center Holdings (TSE:2127) has reported a busy quarter, with Q3 2026 revenue at ¥15.2b and basic EPS of ¥14.53, while trailing 12 month EPS is ¥44.65 on revenue of ¥52.0b. The company’s quarterly revenue has moved from ¥11.3b in Q3 2025 to ¥15.2b in Q3 2026, with basic EPS over that span shifting from ¥9.68 to ¥14.53. This leaves investors to weigh the high reported margins against the sustainability of the recent earnings strength. See our full analysis for Nihon M&A Center...
TSE:5334
TSE:5334Auto Components

Niterra (TSE:5334) Q3 EPS Strength Reinforces Bullish Earnings Power Narrative

Niterra (TSE:5334) has just posted its Q3 2026 numbers, with revenue of ¥174.9b and basic EPS of ¥150.45, giving investors another clean datapoint on how the year is shaping up. The company has seen quarterly revenue move from ¥161.1b in Q3 2025 to ¥174.9b in Q3 2026, while basic EPS has shifted from ¥121.20 to ¥150.45 over the same period. Margins, already in focus thanks to a 14.7% net profit margin over the past year, remain central to the story. See our full analysis for Niterra. With the...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Is Goldman’s Oncology Upgrade Altering The Investment Case For BioNTech’s Pipeline-Driven Future (BNTX)?

Goldman Sachs recently upgraded BioNTech SE to Buy, highlighting the company’s position in next-generation immuno-oncology and antibody-drug conjugates, with key oncology data expected in 2026. This endorsement reinforces BioNTech’s shift from its Covid-focused profile toward building a broader oncology franchise powered by its mRNA and antibody platforms. Next, we’ll examine how Goldman Sachs’ confidence in BioNTech’s oncology pipeline could influence the company’s long-term investment...